Nebula Research & Development’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.4K | Sell |
25,305
-19,405
| -43% | -$73.2K | 0.01% | 924 |
|
|
2025
Q1 | $203K | Sell |
44,710
-3,863
| -8% | -$17.5K | 0.02% | 862 |
|
|
2024
Q4 | $343K | Sell |
48,573
-7,428
| -13% | -$52.5K | 0.04% | 678 |
|
|
2024
Q3 | $456K | Buy |
56,001
+19,963
| +55% | +$162K | 0.05% | 579 |
|
|
2024
Q2 | $230K | Buy |
36,038
+24,625
| +216% | +$157K | 0.04% | 689 |
|
|
2024
Q1 | $85.9K | Sell |
11,413
-30,673
| -73% | -$231K | 0.02% | 694 |
|
|
2023
Q4 | $390K | Buy |
+42,086
| New | +$390K | 0.12% | 332 |
|